To evaluate whether blood glucose and insulin affect fetuin-B secretion, we performed OGTTs to observe changes in serum fetuin-B levels in vivo. A significant increase in serum fetuin-B levels was observed in healthy subjects, but patients with MetS showed no change. Here, INS is linked to metabolic syndrome.